Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000897069-24-002007
Filing Date
2024-10-22
Accepted
2024-10-22 20:41:46
Documents
1
Period of Report
2024-10-18

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 6416
  Complete submission text file 0000897069-24-002007.txt   8050
Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 150 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 150 SAN DIEGO CA 92121 (858) 350-4364
Kintara Therapeutics, Inc. (Issuer) CIK: 0001498382 (see all company filings)

EIN.: 990360497 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O PRECISION BIOSCIENCES, INC. 302 EAST PETTIGREW STREET DURHAM NC 27701
Business Address
List Alan (Reporting) CIK: 0001858530 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37823 | Film No.: 241387604